Article Text

PDF
Heart failure and cardiomyopathy
Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study
  1. Michael Becker1,
  2. Andreas Franke1,
  3. Ole A Breithardt2,
  4. Christina Ocklenburg3,
  5. Theresa Kaminski1,
  6. Rafael Kramann1,
  7. Christian Knackstedt1,
  8. Christoph Stellbrink1,
  9. Peter Hanrath1,
  10. Patrick Schauerte1,
  11. Rainer Hoffmann1
  1. 1
    University RWTH Aachen, Department of Cardiology, Aachen, Germany
  2. 2
    University Mannheim, Department of Cardiology, Mannheim, Germany
  3. 3
    University RWTH Aachen, Department of Medical Statistics, Aachen, Germany
  1. Dr R Hoffmann, Medical Clinic I, University RWTH Aachen, Pauwelsstrasse 30, 52057 Aachen, Germany; rhoffmann{at}UKAACHEN.de

Abstract

Background: Definition of the optimal left ventricular (LV) lead position in cardiac resynchronisation therapy (CRT) is desirable.

Objective: To define the optimal LV lead position in CRT and assess the effectiveness of CRT depending on the LV lead position using new myocardial deformation imaging.

Methods: Myocardial deformation imaging based on tracking of acoustic tissue pixels in two-dimensional echocardiographic images (EchoPAC, GE ultrasound) was performed in 47 patients with heart failure at baseline and during CRT. In a 36-segment LV model the segment with the latest peak systolic circumferential strain before CRT was determined. The segment with maximal temporal difference in peak systolic circumferential strain on CRT compared with before CRT was assumed to be the LV lead position. The optimal LV lead position was defined as concurrence or immediate neighbouring of the segment with the latest contraction before CRT and those with assumed LV lead location.

Results: 25 patients had optimal and 22 non-optimal LV lead positions. Before CRT, the LV ejection fraction (EF) and peak oxygen consumption (Vo2max) were similar in patients with optimal and non-optimal LV lead positions (mean (SD) EF = 31.4 (6.1)% vs 30.3 (6.5)% and Vo2max = 14.2 (1.8) vs 14.0 (2.1) ml/min/kg, respectively). At 3 months on CRT, EF increased by 9 (2)% vs 5 (3)% and Vo2max by 2.0 (0.8) vs 1.1 (0.5) ml/min/kg in the optimal vs non-optimal LV lead position groups, respectively (both p<0.001).

Conclusions: Concordance of the LV lead site and location of the latest systolic contraction before CRT results in greater improvement in EF and cardiopulmonary workload than the non-optimal LV lead position.

  • echocardiography
  • heart failure
  • pacing

Statistics from Altmetric.com

Footnotes

  • Conflict of interest: None declared.

  • Abbreviations:
    AV
    atrioventricular
    CRT
    cardiac resynchronisation therapy
    EF
    ejection fraction
    GS
    global strain
    HF
    heart failure
    LV
    left ventricular
    NYHA
    New York Heart Association
    Vo2max
    peak oxygen consumption

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles